Microneedle device containing recombinant follicle stimulating hormone

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10632065
APP PUB NO 20170348228A1
SERIAL NO

15521101

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a microneedle device comprising: a substrate; a microneedle disposed on the substrate; and a coating layer formed on the microneedle; in which the coating layer comprises a recombinant follicle-stimulating hormone, arginine, and glycerin, in the coating layer, the mass of arginine is 0.07 to 0.75-fold of the mass of the recombinant follicle-stimulating hormone and the mass of glycerin is 0.1 to 2.75-fold of the mass of the recombinant follicle-stimulating hormone.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HISAMITSU PHARMACEUTICAL CO INC408 TASHIRODAIKAN-MACHI TOSU-SHI SAGA 841-0017

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Asada, Hajime Kawasaki, JP 12 55
Ito, Takeshi Kawasaki, JP 444 5451
Nishimura, Shinpei Tsukuba, JP 16 47
Tokumoto, Seiji Tsukuba, JP 64 811

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 28, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 28, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00